Bifogade filer
PDF
Kurs
-2,07%
Likviditet
0,02 MDKK
Kalender
| Tid* | ||
| 2025-11-06 | 13:30 | Kvartalsrapport 2025-Q3 |
| 2025-08-21 | 13:30 | Kvartalsrapport 2025-Q2 |
| 2025-05-08 | 13:30 | Kvartalsrapport 2025-Q1 |
| 2025-02-27 | 08:00 | Bokslutskommuniké 2024 |
| 2024-11-07 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-21 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-16 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
| 2024-05-15 | - | Årsstämma |
| 2024-05-02 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-22 | - | Bokslutskommuniké 2023 |
| 2024-02-05 | - | Extra Bolagsstämma 2024 |
| 2023-11-09 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q2 |
| 2023-06-20 | - | Kvartalsrapport 2023-Q1 |
| 2023-06-13 | - | Extra Bolagsstämma 2023 |
| 2023-05-22 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
| 2023-02-23 | - | Bokslutskommuniké 2022 |
| 2022-11-18 | - | Extra Bolagsstämma 2022 |
| 2022-11-09 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-20 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
| 2022-05-19 | - | Årsstämma |
| 2022-05-05 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-24 | - | Bokslutskommuniké 2021 |
| 2021-11-04 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-19 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-21 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
| 2021-05-20 | - | Årsstämma |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-25 | - | Bokslutskommuniké 2020 |
| 2020-11-05 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-15 | - | X-dag ordinarie utdelning STENO 0.00 DKK |
| 2020-05-14 | - | Årsstämma |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-26 | - | Bokslutskommuniké 2019 |
| 2019-11-06 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-20 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-07 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-21 | - | Bokslutskommuniké 2018 |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Denmark |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO
This information is information that STENOCARE A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided by the contact person below for publication on November 01, 2024.
STENOCARE A/S ("Stenocare" or the "Company") is changing the Board of Directors. Board member Søren Kjær will leave the board. The Company will nominate Rolf Steno to join the Board at the next general meeting.
The Company has accepted the resignation from Board member Søren Kjær and would like to thank him for his contribution to the Board of Directors.
The Company will nominate Rolf Steno to join the Board of Directors at the next general meeting. Rolf Steno has a background in sales and international business development.
Thomas Skovlund Schnegelsberg, CEO Phone: +45 31770060 E-mail: presse@stenocare.com
STENOCARE's Certified Adviser is Keswick Global AG / Phone: +43 1 740 408045 / E-mail: info@keswickglobal.com